Targeted Asthma Therapy

Developer: MedLearning2017

Category: Medical

Add App to Comparison

8.00 installs

ratings

+1.00 monthly installs

trend steady

ASO Keyword Dashboard

Tracking 60 keywords for Targeted Asthma Therapy in Google Play

Developer: MedLearning2017 Category: medical

Targeted Asthma Therapy tracks 60 keywords (no keywords rank yet; 60 need traction). Key metrics: opportunity 71.3, difficulty 39.8.

Explore biologic therapies to improve outcomes in severe asthma

Tracked keywords

0 ranked • 60 not ranking yet

Top 10 coverage

—

Best rank — • Latest leader —

Avg opportunity

71.3

Top keyword: patients

Avg difficulty

39.8

Lower scores indicate easier wins

Opportunity leaders

patients

Opportunity: 74.0 • Difficulty: 39.0 • Rank —

Competitors: 198
63.6
patient

Opportunity: 74.0 • Difficulty: 39.4 • Rank —

Competitors: 200
64.8
participants

Opportunity: 74.0 • Difficulty: 37.0 • Rank —

Competitors: 88
60.9
define

Opportunity: 74.0 • Difficulty: 38.0 • Rank —

Competitors: 291
60.7
supporting

Opportunity: 74.0 • Difficulty: 41.8 • Rank —

Competitors: 456
65.8

Unranked opportunities

patients

Opportunity: 74.0 • Difficulty: 39.0 • Competitors: 198
patient

Opportunity: 74.0 • Difficulty: 39.4 • Competitors: 200
participants

Opportunity: 74.0 • Difficulty: 37.0 • Competitors: 88
define

Opportunity: 74.0 • Difficulty: 38.0 • Competitors: 291
supporting

Opportunity: 74.0 • Difficulty: 41.8 • Competitors: 456

High competition keywords

data

Total apps: 175,442 • Major competitors: 7,022

Latest rank: — • Difficulty: 56.6
provides

Total apps: 167,544 • Major competitors: 5,671

Latest rank: — • Difficulty: 54.1
including

Total apps: 131,577 • Major competitors: 7,790

Latest rank: — • Difficulty: 55.6
latest

Total apps: 129,599 • Major competitors: 5,296

Latest rank: — • Difficulty: 56.0
explore

Total apps: 125,784 • Major competitors: 8,883

Latest rank: — • Difficulty: 57.5

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
program	70	100	46	74 42,790 competing apps Median installs: 1,837 Avg rating: 2.3	—	—	1,325 major competitor apps
including	67	100	56	82 131,577 competing apps Median installs: 2,530 Avg rating: 2.6	—	—	7,790 major competitor apps
explore	67	100	57	81 125,784 competing apps Median installs: 1,913 Avg rating: 2.6	—	—	8,883 major competitor apps
patients	74	100	39	64 9,787 competing apps Median installs: 720 Avg rating: 2.0	—	—	198 major competitor apps
provides	67	100	54	83 167,544 competing apps Median installs: 1,391 Avg rating: 2.3	—	—	5,671 major competitor apps
patient	74	100	39	65 11,503 competing apps Median installs: 607 Avg rating: 2.0	—	—	200 major competitor apps
practical	71	100	44	72 33,917 competing apps Median installs: 934 Avg rating: 2.1	—	—	836 major competitor apps
improve	68	100	52	80 100,893 competing apps Median installs: 1,858 Avg rating: 2.5	—	—	4,988 major competitor apps
benefit	72	100	44	70 23,820 competing apps Median installs: 2,031 Avg rating: 2.2	—	—	798 major competitor apps
type	70	100	52	75 48,586 competing apps Median installs: 4,087 Avg rating: 2.5	—	—	2,833 major competitor apps
approach	73	100	47	68 18,498 competing apps Median installs: 898 Avg rating: 2.2	—	—	465 major competitor apps
initiative	73	100	34	56 3,170 competing apps Median installs: 1,605 Avg rating: 1.8	—	—	82 major competitor apps
across	69	100	61	79 85,100 competing apps Median installs: 1,646 Avg rating: 2.5	—	—	4,664 major competitor apps
personalized	69	100	53	78 82,651 competing apps Median installs: 797 Avg rating: 2.4	—	—	3,576 major competitor apps
latest	67	100	56	82 129,599 competing apps Median installs: 1,809 Avg rating: 2.4	—	—	5,296 major competitor apps
optimize	72	100	45	70 23,322 competing apps Median installs: 502 Avg rating: 2.2	—	—	719 major competitor apps
data	67	100	57	84 175,442 competing apps Median installs: 1,363 Avg rating: 2.3	—	—	7,022 major competitor apps
global	70	100	51	74 44,473 competing apps Median installs: 2,692 Avg rating: 2.5	—	—	3,058 major competitor apps
participants	74	100	37	61 6,591 competing apps Median installs: 576 Avg rating: 2.0	—	—	88 major competitor apps
define	74	100	38	61 6,384 competing apps Median installs: 1,693 Avg rating: 2.4	—	—	291 major competitor apps
complex	71	100	47	72 31,452 competing apps Median installs: 1,380 Avg rating: 2.4	—	—	1,321 major competitor apps
role	73	100	44	67 16,982 competing apps Median installs: 3,264 Avg rating: 2.4	—	—	1,281 major competitor apps
explores	71	100	31	49 1,244 competing apps Median installs: 1,180 Avg rating: 2.4	—	—	44 major competitor apps
supporting	74	100	42	66 13,343 competing apps Median installs: 1,012 Avg rating: 2.3	—	—	456 major competitor apps
improving	73	100	43	69 19,980 competing apps Median installs: 1,512 Avg rating: 2.4	—	—	789 major competitor apps

App Description

Explore biologic therapies to improve outcomes in severe asthma

Asthma is a complex and heterogeneous chronic disease that manifests differently across patient populations, influenced by factors such as age, ethnicity, and comorbid conditions. This program explores the underlying role of type 2 inflammation in asthma pathophysiology and highlights how biomarkers—including eosinophil counts, fractional exhaled nitric oxide (FeNO), and IgE levels—can inform a more personalized approach to treatment. Participants will examine emerging evidence supporting the use of biomarker testing to define asthma phenotypes and optimize therapeutic strategies.

Building on the latest Global Initiative for Asthma (GINA 2025) recommendations, this provides guidance on assessing disease severity, evaluating comorbidities, and identifying patients most likely to benefit from biologic therapy. Clinical data and practical decision-making frameworks will be reviewed that compare anti-IgE, anti–IL-5/5R, anti–IL-4/13, and anti–TSLP biologics, emphasizing their safety, efficacy, and demonstrated benefits in reducing exacerbations and improving lung function.